Cataract Surgery Devices Market 2022-2032 | Global Overview, Size, Trend, and Key Players

The Cataract Surgery Devices Market was valued at US$ 7.4 billion in 2020, and is predicted to advance at a CAGR of 5% from 2022 to 2032. Cataract Surgery is the removal of the eye’s clouded natural lens, and replacing it with an artificial lens that helps restore vision to the eye.

Most cataract patients suffered from blurred vision, if not complete blindness, unless the cataract was surgically removed.

The only way to restore vision and see clearly again is to have the cataract surgically removed.

Cataract surgery is typically performed as an outpatient procedure, and most patients are discharged the same day.

Cataracts are the most common cause of vision impairment worldwide, and they are especially problematic in developing countries, where they frequently result in blindness.

According to the National Institute of Vision. Beginning around the age of 40, the risk of cataract increases with each decade of life. By the age of 75, half of all Americans have cataracts. By the age of 80, 70% of the American population has cataracts.

Cataract Surgery Devices Market: Drivers and Restraints

The global market for cataract surgery devices is being driven by an ageing population and an increase in the prevalence of ocular disorders.

The global market for cataract surgery devices is driven by the ageing population, an increase in the prevalence of ocular disorders, technological advancement in healthcare around the world, and growth in emerging economies.

However, a lack of healthcare insurance, a general lack of awareness about eye disorders, and a lack of primary healthcare infrastructure are some of the factors that act as a barrier for this market.

Cataract Surgery Devices Market: Overview 

With rapid advancements in healthcare technology, an increase in the prevalence of ocular disorders, and an ageing population.

The global market for cataract surgery devices is expected to grow at a healthy rate during the forecast period (2015-2025).

Cataract Surgery Devices Market: Region-wise Outlook

The global cataract surgery devices market is divided into seven key regions based on geography: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and the Middle East and Africa.

Asia-Pacific has the fastest growth due to its large population, while North America and Europe have the fastest growth due to their large geriatric populations.

Cataract Surgery Devices Market: Key Players

Some of the key participating global market players in cataract surgery devices are Carl Zeiss Meditech AG, Bausch & Lomb Inc., Alcon Incorporated, NIDEK Co. Ltd., Essilor International S.A and others.

Browse More Details@ https://www.futuremarketinsights.com/reports/cataract-surgery-devices-market

Comments

Post a Comment

Popular posts from this blog

Autosomal Dominant Polycystic Kidney Disease Treatment Market is Likely to Witness Steady Growth by 2033

According to a recent Future Market Insights report, the global Autosomal Dominant Polycystic Kidney Disease Treatment market demand will grow at a 5.97% CAGR from 2023 to 2033, reaching an estimated value of US$ 2,140 million. One of the primary drivers of market expansion is the availability of special regulatory designations, with an increase in Autosomal Dominant Polycystic Kidney Disease Treatment trials also projected to add to the industry's progress. Furthermore, regulatory authorities are expected to introduce and approve new Autosomal Dominant Polycystic Kidney Disease Treatment drugs, which will drive industry growth. Drug companies profit from market exclusivity for a set amount of time, as well as clinical trial tax benefits and treatment assistance, which helps to increase the market. Technological developments and the development of a wide range of medications are also projected to push market expansion, allowing physicians to better aid patients with Autosomal Domi
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more